Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Effectiveness of the 20-valent Pneumococcal Conjugate Vaccine (PCV20) Among Medicare Fee-for-service Beneficiaries Aged ≥65 Years in the United States

NCT06782282 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06782282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06782282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Effectiveness of the 20-valent Pneumococcal Conjugate Vaccine (PCV20) Among Medicare Fee-for-service Beneficiaries Aged ≥65 Years in the United States
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
January 20, 2025
Completion date
October 30, 2026
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

community-acquired pneumonia (cap)